NCT06899061 2026-03-03
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
AstraZeneca
Phase 1 Active not recruiting
AstraZeneca
Lomond Therapeutics Holdings, Inc.
Zero Helicobacter IGAN Network
Bristol-Myers Squibb
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's